Pulse Generator 688B & 688L
510(k) K841231
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK841231 | Date26 Jun 1984 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Pulse Generator 688B & 688L is an Implantable Pacemaker Pulse-Generator, a Class III medical device designed to generate electrical impulses for regulating cardiac rhythm in patients with bradycardia or other conduction disorders. It delivers timed electrical stimuli to the heart via implanted leads, ensuring consistent and reliable pacing to maintain proper heart function.
This device is intended for single-use implantation and is regulated under FDA 510(k) clearance (K841231) as a high-risk, life-sustaining Class III product. Supplied sterile and intended for surgical implantation by qualified healthcare professionals, it adheres to MRI safety standards for Class III devices. Authorized under the Premarket Approval (PMA) pathway (product code DXY), it was cleared in 1984 for use in cardiovascular applications. Storage and handling must comply with sterile surgical protocols.
Other devices from Siemens Elema AB
Questions
AI-generated answers, 18 Sep 2026
What is the primary clinical purpose of the Pulse Generator 688B & 688L, and how does it function in patients?
The Pulse Generator 688B & 688L is designed to regulate cardiac rhythm in patients with bradycardia or conduction disorders by generating timed electrical impulses. It delivers these stimuli to the heart through implanted leads, ensuring consistent pacing to maintain proper heart function. This makes it essential for patients requiring life-sustaining cardiac support.
Is the Pulse Generator 688B & 688L intended for single-use or reusable applications, and what does this mean for surgical planning?
The device is explicitly intended for single-use implantation only, meaning it is not designed to be removed, cleaned, or reused. This requires surgical planning to account for a new device during implantation, as it must remain sterile and intact until use. Sterile surgical protocols must be followed during handling and implantation.
How should the Pulse Generator 688B & 688L be stored, and what precautions must be taken to maintain its integrity?
Since the device is supplied sterile and intended for surgical implantation, it must be stored according to sterile surgical protocols. This includes keeping it in its original packaging, protecting it from contamination, and adhering to manufacturer guidelines for shelf life and environmental conditions (e.g., temperature, humidity) to ensure sterility and functionality before use.
Does the Pulse Generator 688B & 688L have any specific compatibility considerations, such as MRI safety?
Yes, the device adheres to MRI safety standards for Class III devices, meaning it is designed to be compatible with MRI environments under specific conditions. However, exact MRI compatibility details (e.g., safe scanning parameters) should be verified with the manufacturer’s documentation, as improper exposure could affect performance or patient safety.
What regulatory pathway was used for FDA clearance of the Pulse Generator 688B & 688L, and what does this imply for its risk classification?
The device was cleared under the Premarket Approval (PMA) pathway (product code DXY) and classified as a Class III high-risk, life-sustaining device by the FDA. This pathway is reserved for devices that support or sustain human life and pose significant risks if they fail, reflecting its critical role in cardiovascular function and the rigorous evaluation it underwent.